Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.
Genetic and environmental factors contribute to the etiology of neural tube defects (NTDs). While periconceptional folic acid supplementation is known to significantly reduce the risk of NTDs, folate metabolic pathway related factors do not account for all NTDs. Evidence from mouse models indicates that the tumor protein p53 (TP53) is involved in implantation and normal neural tube development. To determine whether genetic variation in TP53 might contribute to NTD risk in humans, we constructed a high resolution linkage disequilibrium (LD) map of the TP53 genomic region based on genotyping 21 markers in an Irish population. We found that nine of these variants can be used to capture the majority of common variation in the TP53 genomic region. In contrast, the 3-marker haplotype commonly reported in the TP53 literature offers limited coverage of the variation in the gene. We used the expanded set of polymorphisms to measure the influence of TP53 on NTDs using both case-control and family based tests of association. We also assayed a functional variant in the p53 regulator MDM2 (rs2279744). Alleles of three noncoding TP53 markers were associated with NTD risk. A case effect was seen with the GG genotype of rs1625895 in intron 6 (OR = 1.37 [1.04-1.79], P = 0.02). A maternal effect was seen with the 135/135 genotype of the intron 1 VNTR (OR = 1.86 [1.16-2.96], P = 0.01) and the TT genotype of rs1614984 (RR = 0.58 [0.37-0.91], P = 0.02). As multiple comparisons were made, these cannot be considered definitive positive findings and additional investigation is required.
Pangilinan
Faith
F
Molecular Pathogenesis Section, Genome Technology Branch, National Human Genome Research Institute, Bethesda, Maryland 20892-8004, USA.
Geiler
Kerry
K
Dolle
Jessica
J
Troendle
James
J
Swanson
Deborah A
DA
Molloy
Anne M
AM
Sutton
Marie
M
Conley
Mary
M
Kirke
Peadar N
PN
Scott
John M
JM
Mills
James L
JL
Brody
Lawrence C
LC
D000328:Adult; D000704:Analysis of Variance; D016022:Case-Control Studies; D002874:Chromosome Mapping; D005260:Female; D016158:Genes, p53; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D007231:Infant, Newborn; D007494:Ireland; D015810:Linkage Disequilibrium; D008297:Male; D009436:Neural Tube Defects / Q000235:genetics*; D011110:Polymorphism, Genetic; D011247:Pregnancy; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics; D016135:Spinal Dysraphism
C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2
N Engl J Med. 1999 Nov 11;341(20):1509-19
10559453
J Clin Pathol. 2005 Jan;58(1):26-31
15623478
Q J Med. 1993 Nov;86(11):703-8
8265769
Carcinogenesis. 1996 Jun;17(6):1313-6
8681448
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):214-22
17301252
Eur J Hum Genet. 2006 Jun;14(6):768-72
16552426
Oncogene. 2004 Mar 11;23(10):1954-6
14647431
Am J Hum Genet. 2003 Nov;73(5):1162-9
14574645
Carcinogenesis. 1995 Sep;16(9):2233-6
7554081
Int J Cancer. 2007 Dec 1;121(11):2532-8
17683073
Hum Hered. 1996 Jan-Feb;46(1):49-54
8825463
Cell. 2004 Nov 24;119(5):591-602
15550242
Am J Hum Genet. 1998 Apr;62(4):969-78
9529360
Am J Hum Genet. 2001 Apr;68(4):978-89
11254454
JAMA. 1996 Apr 10;275(14):1089-92
8601927
QJM. 1995 Nov;88(11):763-6
8542260
N Engl J Med. 1992 Dec 24;327(26):1832-5
1307234
Mutagenesis. 1993 Jul;8(4):275-83
8377645
Genes Dev. 2002 Mar 15;16(6):676-80
11914272
Curr Biol. 1995 Aug 1;5(8):931-6
7583151
JAMA. 1996 Apr 10;275(14):1093-6
8601928
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3115-20
8610178
Cancer Res. 1994 Sep 15;54(18):4855-78
8069852
Nat Genet. 1999 Oct;23(2):176-84
10508513
Pediatrics. 1990 Jan;85(1):1-9
2404255
Carcinogenesis. 1995 Jul;16(7):1461-4
7614678
Br J Cancer. 1994 Mar;69(3):409-16
8123467
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Epidemiology. 1996 Sep;7(5):507-12
8862982
Pediatr Neurosurg. 2000 Jan;32(1):1-9
10765131
Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):105-12
9037561
JAMA. 1995 Dec 6;274(21):1698-702
7474275
Am J Obstet Gynecol. 1994 Feb;170(2):541-8
8116710
Lancet. 1995 Apr 15;345(8955):994
7715326
BMJ. 2005 Mar 12;330(7491):574-5
15760997
Teratology. 1987 Jun;35(3):465-73
3114906
Am J Hum Genet. 2002 Nov;71(5):1207-15
12384833
Am J Epidemiol. 2000 May 1;151(9):862-77
10791559
Br J Cancer. 1999 Sep;81(1):179-83
10487631
Environ Health Perspect. 1997 Jun;105 Suppl 4:919-26
9255581
Birth Defects Res A Clin Mol Teratol. 2006 Feb;76(2):129-32
16470852
Oncogene. 2006 Mar 13;25(11):1602-11
16550160
Cell. 1991 Nov 15;67(4):767-74
1682057
Lancet. 1991 Jul 20;338(8760):131-7
1677062
J Hum Genet. 2006;51(2):98-103
16315005
J Natl Cancer Inst. 2002 May 1;94(9):681-90
11983757
Nature. 2000 Nov 16;408(6810):307-10
11099028
Nat Genet. 1995 Jun;10(2):175-80
7663512
Nature. 2007 Nov 29;450(7170):721-4
18046411
Clin Chem. 1993 Mar;39(3):549-50
8448878
Br J Cancer. 2005 Jan 17;92(1):30-5
15583690